2002 related articles for article (PubMed ID: 24848508)
1. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
2. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
3. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
4. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Adil A; Godwin M
J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
[TBL] [Abstract][Full Text] [Related]
6. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
8. Male pattern baldness.
Hogan DJ; Chamberlain M
South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
[TBL] [Abstract][Full Text] [Related]
9. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
10. Androgenetic Alopecia: An Update of Treatment Options.
Kelly Y; Blanco A; Tosti A
Drugs; 2016 Sep; 76(14):1349-64. PubMed ID: 27554257
[TBL] [Abstract][Full Text] [Related]
11. Androgenetic Alopecia: Therapy Update.
Devjani S; Ezemma O; Kelley KJ; Stratton E; Senna M
Drugs; 2023 Jun; 83(8):701-715. PubMed ID: 37166619
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
[TBL] [Abstract][Full Text] [Related]
14. A review of medical and surgical treatment options for androgenetic alopecia.
Rousso DE; Kim SW
JAMA Facial Plast Surg; 2014; 16(6):444-50. PubMed ID: 25188680
[TBL] [Abstract][Full Text] [Related]
15. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
17. [Hair loss].
Trüeb RM
Praxis (Bern 1994); 2003 Sep; 92(36):1488-96. PubMed ID: 14526632
[TBL] [Abstract][Full Text] [Related]
18. Management of androgenetic alopecia.
Tosti A; Camacho-Martinez F; Dawber R
J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
[TBL] [Abstract][Full Text] [Related]
19. [Androgenetic alopecia in the man].
Bader U; Trüeb RM
Ther Umsch; 2002 May; 59(5):211-6. PubMed ID: 12090116
[TBL] [Abstract][Full Text] [Related]
20. Promising therapies for treating and/or preventing androgenic alopecia.
McElwee KJ; Shapiro JS
Skin Therapy Lett; 2012 Jun; 17(6):1-4. PubMed ID: 22735503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
